MUFG Americas Holdings Corp - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 291 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 1.33 and the average weighting 0.2%.

Quarter-by-quarter ownership
MUFG Americas Holdings Corp ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2020$4,000
-80.0%
146
-64.0%
0.00%
-100.0%
Q3 2018$20,000
-16.7%
4060.0%0.00%0.0%
Q2 2018$24,000
+26.3%
4060.0%0.00%0.0%
Q1 2018$19,000
-9.5%
406
-23.5%
0.00%0.0%
Q4 2017$21,000
-32.3%
531
-32.0%
0.00%0.0%
Q3 2017$31,000
-6.1%
781
+2.5%
0.00%0.0%
Q2 2017$33,000
+26.9%
762
-8.4%
0.00%0.0%
Q1 2017$26,000
-21.2%
832
-36.5%
0.00%0.0%
Q4 2016$33,000
-29.8%
1,310
-31.1%
0.00%
-50.0%
Q3 2016$47,000
+6.8%
1,902
-12.4%
0.00%0.0%
Q2 2016$44,000
+51.7%
2,171
+15.2%
0.00%
+100.0%
Q1 2016$29,000
-14.7%
1,884
-25.2%
0.00%0.0%
Q4 2015$34,000
-27.7%
2,520
-25.2%
0.00%
-50.0%
Q3 2015$47,000
-17.5%
3,369
+0.6%
0.00%0.0%
Q2 2015$57,000
+67.6%
3,349
+17.9%
0.00%
+100.0%
Q1 2015$34,000
+78.9%
2,840
+25.7%
0.00%0.0%
Q4 2014$19,000
+58.3%
2,260
+65.0%
0.00%
Q3 2014$12,0001,3700.00%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q3 2018
NameSharesValueWeighting ↓
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 426,500$11,754,3403.96%
ASHFORD CAPITAL MANAGEMENT INC 916,747$25,274,7153.72%
ARMISTICE CAPITAL, LLC 5,092,000$140,386,4402.15%
S&T BANK/PA 215,578$5,9431.15%
Aristotle Capital Boston, LLC 1,187,981$32,752,6341.06%
RICE HALL JAMES & ASSOCIATES, LLC 544,468$15,010,9830.95%
Tributary Capital Management, LLC 352,429$9,716,4680.92%
Bridge City Capital, LLC 65,297$1,800,2380.91%
Integral Health Asset Management, LLC 220,000$6,065,4000.84%
Retirement Planning Co of New England, Inc. 51,608$1,422,8330.79%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders